Diabetes
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
Published in Physician Law Weekly, October 24th, 2007
These data were presented at the 45th annual meeting of the Infectious Disease Society of America (IDSA) in San Diego, California. Ceftobiprole is licensed from, and is being co-developed with, Basilea Pharmaceutica Ltd.
Staphylococcus aureus is the predominant Gram-positive+ bacteria associated with many infections,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2007-10-24)
More Articles from Physician Law Weekly
- Active Power, Inc.
Active Power Supplies Power Protection for Critical Medical Facility - Acute Bronchitis Prevention
Scientists at National Cheng-Kung University, Institute of Public Health report research in acute bronchitis prevention - Addiction Medicine
MADD, AMA, NTSB, IIHS and Others Launch Support 21 Coalition - Addiction Medicine
Studies from St. Thomas' Hospital, Emergency Department add new findings in the area of addiction medicine - Adverse Drug Reactions
Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up - American Humane Association
American Humane Association Adds Direct Services in Animal-Assisted Activities and Therapy - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
